A Study Of The Effect Of CE-224535 On Knee OA (Osteoarthritis) Pain

NCT00418782 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

212

Enrollment

INDUSTRY

Sponsor class

Stopped Results of interim analysis indicate lack of efficacy when compared to placebo.

Conditions

Osteoarthritis

Interventions

DRUG: naproxen
DRUG: CE-224535
DRUG: placebo

Sponsor

Pfizer